How To Get $50 GLP-1

Millions of Medicare beneficiaries are about to gain access to GLP-1 weight loss medications for as little as $50 per month through the new Medicare Bridge Program, launching July 1. In this episode of On The Pen, Dave Knapp sits down with obesity medicine expert Angela Fitch to break down exactly who qualifies, how to apply, which medications are covered, and what this historic expansion of obesity treatment access means for patients across America.

We discuss:
✅ Medicare Bridge Program eligibility requirements
✅ Zepbound, Wegovy, Foundayo (orforglipron), and GLP-1 coverage updates
✅ BMI and comorbidity qualifications
✅ Prediabetes, sleep apnea, cardiovascular disease, and obesity treatment access
✅ How Medicare patients can obtain GLP-1 medications
✅ Why obesity is finally being treated as a chronic disease
✅ The future of obesity medicine and Medicare coverage
✅ Concerns about access to care vs access to medication
✅ Muscle loss, nutrition, strength training, and healthy weight loss
✅ The Treat and Reduce Obesity Act (TROA)

This may be one of the most important developments in obesity treatment history, potentially opening the door for millions of Americans living with obesity, prediabetes, cardiovascular disease, and other weight-related conditions to receive evidence-based care.

📖 Read more obesity medicine news at Obesity.News
🔗 All links: linktr.ee/manonthemounjaro

#GLP1 #Medicare #Zepbound #Wegovy #Obesity #WeightLoss #ObesityMedicine #MedicareBridgeProgram #Tirzepatide #Semaglutide #Foundayo #Orforglipron #Prediabetes #Type2Diabetes #WeightManagement #AngelaFitch #OnThePen #MedicareCoverage #GLP1News #ObesityTreatment #HealthcarePolicy #WeightLossMedication #ChronicDisease #Mounjaro #Retatrutide #Lilly #NovoNordisk #ObesityAdvocacy #GLP1Community #MedicarePatients